FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108864264> ?p ?o ?g. }

• W3108864264 abstract "Background: Since a greater number of hepatitis C virus (HCV) patients have access to direct-acting antiviral (DAA) based therapies, the number of patients not properly responding to prior DAA regimens is increasing. The objective of this comprehensive analysis was to assess the efficacy and safety of glecaprevir/pibrentasvir (GLE/PIB) in HCV patients who experienced previous DAA therapy failures. Methods: Bibliographic databases were systematically searched for relevant articles published by November 2020. The main endpoints were sustained viral response after 12 weeks (SVR12), adverse events (AEs; any grade) and severe adverse events (SAEs). Publication bias assessment was performed using funnel plots and the Egger's test. Results: Fourteen studies consisting of a total of 1,294 subjects were included in this study and the pooled estimate of SVR12, AEs and SAEs rates were 96.8% (95%CI: 95.1–98.2), 47.1% (95%CI: 26.0–69.3), and 1.8% (95%CI: 0.7–3.4), respectively. Subgroup analysis showed that pooled SVR12 rates were 97.9% (95%CI: 96.7–98.9) for Japan and 91.1% (95%CI: 87.3–94.3) for the United States; 95.8% (95%CI: 93.9–97.4) for genotype (GT)1 and 100.0% (95%CI: 99.6–100.0) for GT2; 95.3% (95%CI: 92.4–97.2) for cirrhosis and 96.3% (95%CI: 94.2–97.7) for non-cirrhosis cases. There was no publication bias included this study. Conclusion: This comprehensive analysis revealed that GLE/PIB is an effective and secure retreatment option for patients who did not optimally respond to DAA treatment, especially the Asian population with GT1-2." @default.
• W3108864264 created "2020-12-07" @default.
• W3108864264 creator A5000743750 @default.
• W3108864264 creator A5005303316 @default.
• W3108864264 creator A5018244906 @default.
• W3108864264 creator A5023874610 @default.
• W3108864264 creator A5027835055 @default.
• W3108864264 creator A5042824297 @default.
• W3108864264 creator A5043235235 @default.
• W3108864264 creator A5048071821 @default.
• W3108864264 creator A5053696666 @default.
• W3108864264 creator A5062525338 @default.
• W3108864264 creator A5077329360 @default.
• W3108864264 date "2020-12-03" @default.
• W3108864264 modified "2023-10-17" @default.
• W3108864264 title "Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis" @default.
• W3108864264 cites W2024530015 @default.
• W3108864264 cites W2025524023 @default.
• W3108864264 cites W2110633314 @default.
• W3108864264 cites W2133036275 @default.
• W3108864264 cites W2174486220 @default.
• W3108864264 cites W2310608561 @default.
• W3108864264 cites W2336218237 @default.
• W3108864264 cites W2343674560 @default.
• W3108864264 cites W2413213127 @default.
• W3108864264 cites W2507564331 @default.
• W3108864264 cites W2576440140 @default.
• W3108864264 cites W2578013986 @default.
• W3108864264 cites W2588942442 @default.
• W3108864264 cites W2594626196 @default.
• W3108864264 cites W2605698336 @default.
• W3108864264 cites W2746084941 @default.
• W3108864264 cites W2756644889 @default.
• W3108864264 cites W2761085897 @default.
• W3108864264 cites W2762048449 @default.
• W3108864264 cites W2765116944 @default.
• W3108864264 cites W2768486652 @default.
• W3108864264 cites W2784719900 @default.
• W3108864264 cites W2792190643 @default.
• W3108864264 cites W2885280882 @default.
• W3108864264 cites W2889750687 @default.
• W3108864264 cites W2896376232 @default.
• W3108864264 cites W2906693379 @default.
• W3108864264 cites W2916747295 @default.
• W3108864264 cites W2935938937 @default.
• W3108864264 cites W2936835741 @default.
• W3108864264 cites W2942541802 @default.
• W3108864264 cites W2948264438 @default.
• W3108864264 cites W2950710959 @default.
• W3108864264 cites W2955910316 @default.
• W3108864264 cites W2964348153 @default.
• W3108864264 cites W2964985962 @default.
• W3108864264 cites W2967406066 @default.
• W3108864264 cites W2978795816 @default.
• W3108864264 cites W2980993301 @default.
• W3108864264 cites W3009290908 @default.
• W3108864264 cites W3015084081 @default.
• W3108864264 cites W4241157840 @default.
• W3108864264 cites W4293217959 @default.
• W3108864264 doi "https://doi.org/10.3389/fmed.2020.592472" @default.
• W3108864264 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7793883" @default.
• W3108864264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33425940" @default.
• W3108864264 hasPublicationYear "2020" @default.
• W3108864264 type Work @default.
• W3108864264 sameAs 3108864264 @default.
• W3108864264 citedByCount "4" @default.
• W3108864264 countsByYear W31088642642022 @default.
• W3108864264 countsByYear W31088642642023 @default.
• W3108864264 crossrefType "journal-article" @default.
• W3108864264 hasAuthorship W3108864264A5000743750 @default.
• W3108864264 hasAuthorship W3108864264A5005303316 @default.
• W3108864264 hasAuthorship W3108864264A5018244906 @default.
• W3108864264 hasAuthorship W3108864264A5023874610 @default.
• W3108864264 hasAuthorship W3108864264A5027835055 @default.
• W3108864264 hasAuthorship W3108864264A5042824297 @default.
• W3108864264 hasAuthorship W3108864264A5043235235 @default.
• W3108864264 hasAuthorship W3108864264A5048071821 @default.
• W3108864264 hasAuthorship W3108864264A5053696666 @default.
• W3108864264 hasAuthorship W3108864264A5062525338 @default.
• W3108864264 hasAuthorship W3108864264A5077329360 @default.
• W3108864264 hasBestOaLocation W31088642641 @default.
• W3108864264 hasConcept C126322002 @default.
• W3108864264 hasConcept C159047783 @default.
• W3108864264 hasConcept C187960798 @default.
• W3108864264 hasConcept C197934379 @default.
• W3108864264 hasConcept C2522874641 @default.
• W3108864264 hasConcept C2776408679 @default.
• W3108864264 hasConcept C2777214474 @default.
• W3108864264 hasConcept C2780439572 @default.
• W3108864264 hasConcept C71924100 @default.
• W3108864264 hasConcept C82605166 @default.
• W3108864264 hasConcept C90924648 @default.
• W3108864264 hasConcept C95190672 @default.
• W3108864264 hasConceptScore W3108864264C126322002 @default.
• W3108864264 hasConceptScore W3108864264C159047783 @default.
• W3108864264 hasConceptScore W3108864264C187960798 @default.
• W3108864264 hasConceptScore W3108864264C197934379 @default.
• W3108864264 hasConceptScore W3108864264C2522874641 @default.
• W3108864264 hasConceptScore W3108864264C2776408679 @default.
• W3108864264 hasConceptScore W3108864264C2777214474 @default.

• next